US EditionPublished • loading... • Updated
Obesity Market Sales Potential Tightens as Novo and Lilly Enter New Era
Falling U.S. prices and intensifying competition have reduced peak global obesity drug market forecasts by about 30%, with estimates now near $100 billion by 2030.
Summary by WTVB
3 Articles
3 Articles
Pharmalittle: We're reading about obesity drug sales, India's biopharma research push, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online meetings, and phone calls has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction by brewing cups of stimulation. Our choice today is marshmallow magic. Meanwhile, here are a few items of…
·Boston, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
